Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:ICEL
Date7/2013
Raised$57.3M
Post IPO Valuation

General Information

Websitecellulardynamics.com
Twitter@CellDynamics
CategoryBioTech
Phone(608) 310-5100
Employees
Founded2004

Offices

Madison, USA
525 Science Drive
Madison, WI, 53711
USA

People

Founder, Chief Scientific Officer & Board of Directors
Founder, Board of Directors
Founder
Founder
Chairman of the Board and Chief Executive Officer, Founders & Board of Directors
Vice President and Chief Commercial Officer
Vice President and Chief Technology Officer
Vice President and Chief Financial Officer
Show All People

Funding

TOTAL $91.6M
FUNDING TOTAL $91.6M
Series B, 4/2010
Tactics II Stem Cell Ventures
Sam Zell’s Equity Group Investments
Sixth Floor Investors
$40.6M
Series B, 4/2011
Tactics II Stem Cell Ventures
$30M
Private Equity, 11/2012
$21M
DEBT TOTAL $20M
Debt, 7/2013
$20M

Tags

Cellular Dynamics International

Cellular Dynamics International, Inc. develops stem cell technologies for drug development and personalized medicine applications. It offers drug screening and toxicity testing products based on induced pluripotent stem (iPS) cell technology. The company also provides cardiac toxicity drug testing services, including GLP and non-GLP hERG electrophysiological assays, as well as action potential and cytotoxicity screens using cardiomycytes. In addition, it offers pluripotent stem cell derived products, including cardiomyocytes, hematopoietic cells, neural cells, and hepatocytes. Cellular Dynamics International, Inc. was formerly known as iPS Cells Inc. and changed its name to Cellular Dynamics International, Inc. in July 2008. The company was founded in 2004 and is based in Madison, Wisconsin.

Recent Milestones

Videos

Screenshots

Cellular Dynamics International screenshot
Above: Home Page
Uploaded: 5/5/10

Stock Price

Sources

  1. Stem cell legend attracts $40M round for preclinical testing tech (fiercebiotech.com) [edit]
  2. Cellular Dynamics Raises $30 Million to Expand Its Product Line of Human Stem Cells and Tissue Cells (money.msn.com) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
Edit This Page
Last Edited 4/4/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy